Type 2 diabetes mellitus has been on the rise in recent years. A major cause of death in the
United States is myocardial infarction with underlying coronary artery disease. Impairment of …

Randomized trials inform the use of implantable cardioverter–defibrillators (ICDs) for
prevention of sudden cardiac death, yet management of patients considering ICD generator …

Background As patients derive variable benefit from generator changes (GCs) of
implantable cardioverter‐defibrillators (ICDs) with an original primary prevention (PP) …

Among primary prevention implantable cardioverter-defibrillator (ICD) recipients, 75% do not
experience any appropriate ICD therapies during their lifetime, and nearly 25% have …

Background Advances in medical treatment and outcomes in implantable cardioverter-
defibrillator (ICD) recipients incentivize a need for improved candidate selection and …

2 ventricular ejection fraction (LVEF). ICD batteries, however, have a limited life span, and
when a battery reaches the end of its life, the generator needs to be replaced if the device is …

Background: Uncertainty still surrounds implantable cardioverter defibrillator (ICD) generator
change at time of elective replacement indicator, in primary prevention patients with …

Background Implantable cardioverter‐defibrillator (ICD) is associated with reduction in
arrhythmic mortality. However, at the time of generator replacement (GR) some patients had …

Background Left ventricular ejection fraction (LVEF) is used to select patients for primary
prevention implantable cardioverter defibrillators (ICDs). The relationship between baseline …

Está demostrado que los desfibriladores automáticos implantables (DAI) reducen la
mortalidad cardiovascular de los pacientes con cardiopatías con elevado riesgo arrítmico …